Analysing the effect of novel therapies on cytokine expression in experimental arthritis.
Type II collagen-induced arthritis (CIA) is an animal model of rheumatoid arthritis that has been used extensively to address questions of disease pathogenesis and to validate novel therapeutic targets. Susceptibility to CIA is strongly associated with major histocompatibility complex class II genes...
Main Authors: | Williams, R, Inglis, J, Simelyte, E, Criado, G, Sumariwalla, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis.
by: Simelyte, E, et al.
Published: (2008) -
Protocol for the induction of arthritis in C57BL/6 mice.
by: Inglis, J, et al.
Published: (2008) -
Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
by: Criado, G, et al.
Published: (2009) -
Cytokine therapy in rheumatoid arthritis.
by: Maini, R, et al.
Published: (1996) -
Cytokine expression in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1991)